Your browser doesn't support javascript.
loading
Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA.
Léveillé, Nicolas; Melo, Carlos A; Rooijers, Koos; Díaz-Lagares, Angel; Melo, Sonia A; Korkmaz, Gozde; Lopes, Rui; Moqadam, Farhad Akbari; Maia, Ana R; Wijchers, Patrick J; Geeven, Geert; den Boer, Monique L; Kalluri, Raghu; de Laat, Wouter; Esteller, Manel; Agami, Reuven.
Afiliación
  • Léveillé N; Division of Biological Stress Response, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
  • Melo CA; Division of Biological Stress Response, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
  • Rooijers K; Doctoral Programme in Biomedicine and Experimental Biology, Centre for Neuroscience and Cell Biology, Coimbra University, 3004-504 Coimbra, Portugal.
  • Díaz-Lagares A; Division of Biological Stress Response, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
  • Melo SA; Division of Cancer Epigenetics, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia 08908, Spain.
  • Korkmaz G; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA.
  • Lopes R; Division of Biological Stress Response, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
  • Moqadam FA; Division of Biological Stress Response, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
  • Maia AR; Department of Pediatric Oncology and Hematology, Erasmus University Medical Center, Erasmus MC, 3015 CE Rotterdam, The Netherlands.
  • Wijchers PJ; Department of Cell Biology and Cancer Genomics Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
  • Geeven G; Hubrecht Institute-KNAW, University Medical Centre Utrecht, Uppsalalaan 8, 3584CT Utrecht, The Netherlands.
  • den Boer ML; Hubrecht Institute-KNAW, University Medical Centre Utrecht, Uppsalalaan 8, 3584CT Utrecht, The Netherlands.
  • Kalluri R; Department of Pediatric Oncology and Hematology, Erasmus University Medical Center, Erasmus MC, 3015 CE Rotterdam, The Netherlands.
  • de Laat W; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA.
  • Esteller M; Hubrecht Institute-KNAW, University Medical Centre Utrecht, Uppsalalaan 8, 3584CT Utrecht, The Netherlands.
  • Agami R; Division of Cancer Epigenetics, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia 08908, Spain.
Nat Commun ; 6: 6520, 2015 Mar 27.
Article en En | MEDLINE | ID: mdl-25813522
ABSTRACT
p53 binds enhancers to regulate key target genes. Here, we globally mapped p53-regulated enhancers by looking at enhancer RNA (eRNA) production. Intriguingly, while many p53-induced enhancers contained p53-binding sites, most did not. As long non-coding RNAs (lncRNAs) are prominent regulators of chromatin dynamics, we hypothesized that p53-induced lncRNAs contribute to the activation of enhancers by p53. Among p53-induced lncRNAs, we identified LED and demonstrate that its suppression attenuates p53 function. Chromatin-binding and eRNA expression analyses show that LED associates with and activates strong enhancers. One prominent target of LED was located at an enhancer region within CDKN1A gene, a potent p53-responsive cell cycle inhibitor. LED knockdown reduces CDKN1A enhancer induction and activity, and cell cycle arrest following p53 activation. Finally, promoter-associated hypermethylation analysis shows silencing of LED in human tumours. Thus, our study identifies a new layer of complexity in the p53 pathway and suggests its dysregulation in cancer.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Adenocarcinoma / Regulación Neoplásica de la Expresión Génica / Proteína p53 Supresora de Tumor / Metilación de ADN / ARN Largo no Codificante Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Adenocarcinoma / Regulación Neoplásica de la Expresión Génica / Proteína p53 Supresora de Tumor / Metilación de ADN / ARN Largo no Codificante Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos